X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (4) 4
humans (4) 4
index medicus (4) 4
adult (3) 3
aged (3) 3
cancer (3) 3
male (3) 3
middle aged (3) 3
neoplasm staging (3) 3
oncology (3) 3
treatment outcome (3) 3
cancer therapies (2) 2
chemotherapy (2) 2
clinical trials (2) 2
combination (2) 2
disease-free survival (2) 2
double-blind method (2) 2
drug administration schedule (2) 2
medical colleges (2) 2
proportional hazards models (2) 2
survival analysis (2) 2
tumors (2) 2
3d slicer (1) 1
abdomen (1) 1
adjuvant treatment (1) 1
adjuvants, immunologic - administration & dosage (1) 1
adjuvants, immunologic - adverse effects (1) 1
adjuvants, immunologic - therapeutic use (1) 1
adolescent (1) 1
aged, 80 and over (1) 1
analysis (1) 1
angiogenesis (1) 1
angiogenesis inhibitors (1) 1
angiogenesis inhibitors - administration & dosage (1) 1
antiangiogenesis therapy (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic agents - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols - administration & dosage (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
arachnoid cysts (1) 1
area under curve (1) 1
bevacizumab (1) 1
biochemistry (1) 1
bioindicators (1) 1
biology and life sciences (1) 1
biomarkers (1) 1
biomarkers, tumor - blood (1) 1
biomarkers, tumor - metabolism (1) 1
biometrics (1) 1
brain diseases (1) 1
breast cancer (1) 1
breast neoplasms - drug therapy (1) 1
breast neoplasms - mortality (1) 1
breast neoplasms - pathology (1) 1
breast neoplasms - surgery (1) 1
cancer treatment (1) 1
cancers and neoplasms (1) 1
carboplatin (1) 1
carboplatin - administration & dosage (1) 1
carcinoma, non-small-cell lung - drug therapy (1) 1
carcinoma, non-small-cell lung - mortality (1) 1
care and treatment (1) 1
cell lung-cancer (1) 1
chemotherapy, adjuvant (1) 1
child (1) 1
child, preschool (1) 1
chills - chemically induced (1) 1
clinical medicine (1) 1
clinical neurology (1) 1
clinical research design (1) 1
college teachers (1) 1
colony-stimulating factor (1) 1
continuity (1) 1
corporate sponsorship (1) 1
cysts (1) 1
data analysis (1) 1
data collection (1) 1
data processing (1) 1
design factors (1) 1
diagnosis (1) 1
diagnostic medicine (1) 1
domain (1) 1
dose-response relationship, drug (1) 1
efficacy (1) 1
endoscopy (1) 1
endothelial growth-factor (1) 1
estrogen-receptor (1) 1
experimental design (1) 1
extent (1) 1
fatigue - chemically induced (1) 1
feasibility studies (1) 1
fever - chemically induced (1) 1
follow-up studies (1) 1
granulocyte-macrophage colony-stimulating factor - drug effects (1) 1
granulocyte-macrophage colony-stimulating factor - immunology (1) 1
hazards (1) 1
health hazards (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 3, pp. 367 - 377
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2015, Volume 33, Issue 25, pp. 2780 - 2788
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2014, Volume 9, Issue 10, p. e108048
Purpose: We sought to develop placental growth factor as a predictive pharmacodynamic biomarker for motesanib efficacy as first-line therapy in patients with... 
CELL LUNG-CANCER | REVASCULARIZATION | CARBOPLATIN | SOLID TUMORS | BEVACIZUMAB | THYROID-CANCER | MULTIDISCIPLINARY SCIENCES | PHASE-II | COMBINATION | MULTIKINASE INHIBITOR | ENDOTHELIAL GROWTH-FACTOR | Niacinamide - analogs & derivatives | Lung Neoplasms - drug therapy | Area Under Curve | Lung Neoplasms - mortality | Humans | Middle Aged | Male | Indoles - administration & dosage | Pregnancy Proteins - blood | Angiogenesis Inhibitors - administration & dosage | Biomarkers, Tumor - metabolism | Female | Paclitaxel - administration & dosage | Double-Blind Method | Drug Administration Schedule | Placebo Effect | Proportional Hazards Models | Carboplatin - administration & dosage | Survival Rate | Carcinoma, Non-Small-Cell Lung - mortality | Niacinamide - administration & dosage | Biomarkers, Tumor - blood | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Placenta Growth Factor | ROC Curve | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasm Staging | Biometrics | Laboratories | Lung cancer | Kinases | Cancer therapies | Angiogenesis | Randomization | Paclitaxel | Bioindicators | Vascular endothelial growth factor | Continuity (mathematics) | Data analysis | Research & development--R&D | Data processing | Hazards | Pharmacology | Patients | Survival | Studies | Chemotherapy | Placenta | Statistical models | Experimental design | Health hazards | Biomarkers | Carboplatin | Design factors | Angiogenesis inhibitors | Cancer | Tumors | Research & development | R&D
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.